Tyra Biosciences, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
CCCC
C4 Therapeutics, Inc. |
$3.89 | $320.64 M | -1.97 | 145 | $20.76 M |
CGEM
Cullinan Oncology, Inc. |
$10.36 | $1.29 B | -7.16 | 85 | $0 |
CNTB
Connect Biopharma Holdings Limited |
$1.03 | $108.00 M | -1.81 | 81 | $0 |
DSGN
Design Therapeutics, Inc. |
$5.00 | $217.51 M | -3.7 | 54 | $0 |
ERAS
Erasca, Inc. |
$1.93 | $647.94 M | -2.83 | 126 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$26.50 | $1.65 B | -11.47 | 108 | $0 |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.79 | $243.38 M | -1.59 | 133 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
HOWL
Werewolf Therapeutics, Inc. |
$1.38 | $151.66 M | -3.17 | 45 | $19.94 M |
IKNA
Ikena Oncology, Inc. |
$1.48 | $84.45 M | -1.11 | 14 | $9.16 M |
IPSC
Century Therapeutics, Inc. |
$0.89 | $244.54 M | -1.32 | 152 | $2.24 M |
MLYS
Mineralys Therapeutics, Inc. |
$10.09 | $652.38 M | -6.03 | 28 | $0 |
MOLN
Molecular Partners AG |
$5.30 | $135.05 M | -2.03 | 167 | $7.04 M |
PHVS
Pharvaris N.V. |
$19.18 | $843.31 M | -5.8 | 83 | $0 |
PMVP
PMV Pharmaceuticals, Inc. |
$1.35 | $85.40 M | -1.26 | 63 | $0 |
RAPT
RAPT Therapeutics, Inc. |
$1.28 | $134.03 M | -1.25 | 70 | $0 |
STOK
Stoke Therapeutics, Inc. |
$9.76 | $774.50 M | -6.14 | 110 | $8.78 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
XLO
Xilio Therapeutics, Inc. |
$0.95 | $38.76 M | -0.41 | 73 | $0 |